These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 28274115)

  • 1. Progress in Nanotheranostics Based on Mesoporous Silica Nanomaterial Platforms.
    Singh RK; Patel KD; Leong KW; Kim HW
    ACS Appl Mater Interfaces; 2017 Mar; 9(12):10309-10337. PubMed ID: 28274115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous/Endogenous-Triggered Mesoporous Silica Cancer Nanomedicine.
    Yang B; Chen Y; Shi J
    Adv Healthc Mater; 2018 Oct; 7(20):e1800268. PubMed ID: 29938917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advancements in mesoporous silica nanoparticles towards therapeutic applications for cancer.
    Li T; Shi S; Goel S; Shen X; Xie X; Chen Z; Zhang H; Li S; Qin X; Yang H; Wu C; Liu Y
    Acta Biomater; 2019 Apr; 89():1-13. PubMed ID: 30797106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.
    Chen F; Hong H; Goel S; Graves SA; Orbay H; Ehlerding EB; Shi S; Theuer CP; Nickles RJ; Cai W
    ACS Nano; 2015; 9(4):3926-34. PubMed ID: 25843647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
    Chan MH; Lin HM
    Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
    Chen Y; Chen H; Shi J
    Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Redox-Responsive Mesoporous Silica Nanoparticles for Efficient Targeting Drug Delivery and Magnetic Resonance Imaging.
    Chen L; Zhou X; Nie W; Zhang Q; Wang W; Zhang Y; He C
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33829-33841. PubMed ID: 27960384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in Multicompartment Mesoporous Silica Micro/Nanoparticles for Theranostic Applications.
    Liu J; Liu T; Pan J; Liu S; Lu GQM
    Annu Rev Chem Biomol Eng; 2018 Jun; 9():389-411. PubMed ID: 29618224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
    Zhang W; Liu M; Liu A; Zhai G
    Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIR-fluorescent dye doped silica nanoparticles for in vivo imaging, sensing and theranostic.
    Rampazzo E; Genovese D; Palomba F; Prodi L; Zaccheroni N
    Methods Appl Fluoresc; 2018 Mar; 6(2):022002. PubMed ID: 28952461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional mesoporous silica nanoparticles for bio-imaging applications.
    Cha BG; Kim J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jan; 11(1):e1515. PubMed ID: 29566308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.
    Ellison PA; Chen F; Goel S; Barnhart TE; Nickles RJ; DeJesus OT; Cai W
    ACS Appl Mater Interfaces; 2017 Mar; 9(8):6772-6781. PubMed ID: 28165700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Decorated Core@Shell Janus Nanoparticles as a Flexible Platform for Targeted Multimodal Molecular Bioimaging of Cancer.
    Sánchez A; Ovejero Paredes K; Ruiz-Cabello J; Martínez-Ruíz P; Pingarrón JM; Villalonga R; Filice M
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):31032-31043. PubMed ID: 30141615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid smart mesoporous silica nanoparticles for theranostics.
    Baleizão C; Farinha JP
    Nanomedicine (Lond); 2015; 10(15):2311-4. PubMed ID: 26227810
    [No Abstract]   [Full Text] [Related]  

  • 19. Theragnostic potentials of core/shell mesoporous silica nanostructures.
    Ravindran Girija A; Balasubramanian S
    Nanotheranostics; 2019; 3(1):1-40. PubMed ID: 30662821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality Imaging of Silica and Silicon Materials In Vivo.
    Karaman DŞ; Sarparanta MP; Rosenholm JM; Airaksinen AJ
    Adv Mater; 2018 Jun; 30(24):e1703651. PubMed ID: 29388264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.